Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Ross

Showing results (251-260 of 345) with videos related to

Pageof 35
Sort By:
European Journal of Immunology|November 25, 2003
Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigeneAnahit Ghochikyan, Vitaly Vasilevko, Irina Petrushina, et al.
Journal of Virology|November 2, 2012
Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virusDonald M Carter, Chalise E Bloom, Eduardo J M Nascimento, et al.
Human Vaccines & Immunotherapeutics|September 19, 2013
Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic miceLeonard Moise, Ryan Tassone, Howard Latimer, et al.
Vaccine|November 7, 2025
Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort studyCong Cheng, Xianyan Chen, Yang Ge, et al.
Vaccine|February 5, 2025
Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC studyYang Ge, Andreas Handel, Philippe J Giabbanelli, et al.
International Journal of Pharmaceutics|July 16, 2022
Formulation of dry powders of vaccines containing MF59 or AddaVax by Thin-Film Freeze-Drying: Towards a dry powder universal flu vaccineKhaled AboulFotouh, Naoko Uno, Haiyue Xu, et al.
Immunology and Cell Biology|November 12, 2014
C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cellsAnne S De Groot, Ted M Ross, Lauren Levitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expressionKaren M Haas, Franklin R Toapanta, Julie A Oliver, et al.
Cell Reports. Medicine|March 15, 2023
Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccinationCarolyn M Boudreau, John S Burke, Alexander L Roederer, et al.
Vaccines|August 23, 2020
High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell LinesJeffrey W Ecker, Greg A Kirchenbaum, Spencer R Pierce, et al.
Pageof 35

Showing results (251-260 of 345) with videos related to

Sort By:
Pageof 35
European Journal of Immunology|November 25, 2003
Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigeneAnahit Ghochikyan, Vitaly Vasilevko, Irina Petrushina, et al.
Journal of Virology|November 2, 2012
Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virusDonald M Carter, Chalise E Bloom, Eduardo J M Nascimento, et al.
Human Vaccines & Immunotherapeutics|September 19, 2013
Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic miceLeonard Moise, Ryan Tassone, Howard Latimer, et al.
Vaccine|November 7, 2025
Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort studyCong Cheng, Xianyan Chen, Yang Ge, et al.
Vaccine|February 5, 2025
Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC studyYang Ge, Andreas Handel, Philippe J Giabbanelli, et al.
International Journal of Pharmaceutics|July 16, 2022
Formulation of dry powders of vaccines containing MF59 or AddaVax by Thin-Film Freeze-Drying: Towards a dry powder universal flu vaccineKhaled AboulFotouh, Naoko Uno, Haiyue Xu, et al.
Immunology and Cell Biology|November 12, 2014
C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cellsAnne S De Groot, Ted M Ross, Lauren Levitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expressionKaren M Haas, Franklin R Toapanta, Julie A Oliver, et al.
Cell Reports. Medicine|March 15, 2023
Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccinationCarolyn M Boudreau, John S Burke, Alexander L Roederer, et al.
Vaccines|August 23, 2020
High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell LinesJeffrey W Ecker, Greg A Kirchenbaum, Spencer R Pierce, et al.
Pageof 35